206 related articles for article (PubMed ID: 20979633)
1. SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology.
Barrington J; Wereko-Brobby O; Ward P; Mwafongo W; Kungulwe S
Malar J; 2010 Oct; 9():298. PubMed ID: 20979633
[TBL] [Abstract][Full Text] [Related]
2. The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania.
Mikkelsen-Lopez I; Shango W; Barrington J; Ziegler R; Smith T; deSavigny D
Malar J; 2014 May; 13():181. PubMed ID: 24885420
[TBL] [Abstract][Full Text] [Related]
3. Reducing stock-outs of life saving malaria commodities using mobile phone text-messaging: SMS for life study in Kenya.
Githinji S; Kigen S; Memusi D; Nyandigisi A; Mbithi AM; Wamari A; Muturi AN; Jagoe G; Barrington J; Snow RW; Zurovac D
PLoS One; 2013; 8(1):e54066. PubMed ID: 23349786
[TBL] [Abstract][Full Text] [Related]
4. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
[TBL] [Abstract][Full Text] [Related]
5. The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
Sudoi RK; Githinji S; Nyandigisi A; Muturi A; Snow RW; Zurovac D
Malar J; 2012 Feb; 11():37. PubMed ID: 22316236
[TBL] [Abstract][Full Text] [Related]
6. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
7. Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
Njogu J; Akhwale W; Hamer DH; Zurovac D
East Afr Med J; 2008 May; 85(5):213-21. PubMed ID: 18814531
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia.
Leung NH; Chen A; Yadav P; Gallien J
PLoS One; 2016; 11(5):e0156026. PubMed ID: 27227412
[TBL] [Abstract][Full Text] [Related]
9. Beyond antimalarial stock-outs: implications of health provider compliance on out-of-pocket expenditure during care-seeking for fever in South East Tanzania.
Mikkelsen-Lopez I; Tediosi F; Abdallah G; Njozi M; Amuri B; Khatib R; Manzi F; de Savigny D
BMC Health Serv Res; 2013 Oct; 13():444. PubMed ID: 24161029
[TBL] [Abstract][Full Text] [Related]
10. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Simba D; Kakoko D
Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
[TBL] [Abstract][Full Text] [Related]
11. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Sabot OJ; Mwita A; Cohen JM; Ipuge Y; Gordon M; Bishop D; Odhiambo M; Ward L; Goodman C
PLoS One; 2009 Sep; 4(9):e6857. PubMed ID: 19724644
[TBL] [Abstract][Full Text] [Related]
12. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.
Cohen JM; Sabot O; Sabot K; Gordon M; Gross I; Bishop D; Odhiambo M; Ipuge Y; Ward L; Mwita A; Goodman C
BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S6. PubMed ID: 20594372
[TBL] [Abstract][Full Text] [Related]
13. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.
Kangwana BB; Njogu J; Wasunna B; Kedenge SV; Memusi DN; Goodman CA; Zurovac D; Snow RW
Am J Trop Med Hyg; 2009 May; 80(5):737-8. PubMed ID: 19407116
[TBL] [Abstract][Full Text] [Related]
14. Drug procurement, the Global Fund and misguided competition policies.
Tren R; Hess K; Bate R
Malar J; 2009 Dec; 8():305. PubMed ID: 20028536
[TBL] [Abstract][Full Text] [Related]
15. Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.
Kabanywanyi AM; Mulure N; Migoha C; Malila A; Lengeler C; Schlienger R; Genton B
Malar J; 2010 Jul; 9():205. PubMed ID: 20630066
[TBL] [Abstract][Full Text] [Related]
16. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
17. Correct dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter?
Masanja IM; Selemani M; Khatib RA; Amuri B; Kuepfer I; Kajungu D; de Savigny D; Kachur SP; Skarbinski J
Malar J; 2013 Dec; 12():446. PubMed ID: 24325267
[TBL] [Abstract][Full Text] [Related]
18. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
[TBL] [Abstract][Full Text] [Related]
19. The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy.
O'Meara WP; Obala A; Thirumurthy H; Khwa-Otsyula B
Malar J; 2013 Jun; 12():186. PubMed ID: 23738604
[TBL] [Abstract][Full Text] [Related]
20. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
